期刊文献+

抑郁症的神经生物学基础 被引量:13

Neurobiological basis of depression
下载PDF
导出
摘要 目前抑郁症的患病率呈上升的趋势,已成为危害人类健康的常见病。研究显示抑郁症有其神经生物学基础,本文结合近年来的研究进展,从中枢神经系统组织形态结构、中枢神经递质及其受体功能和神经内分泌功能这三个方面的变化,对抑郁症的发病机理作一介绍。
作者 张凌 毛玉婷
出处 《生物学教学》 北大核心 2005年第9期5-7,共3页 Biology Teaching
  • 相关文献

参考文献10

  • 1Sheline YI, Mittler BL, Mintun MA. 2002. The hippocampus and depression. European Psytchiatry, 17 ( Supplement 3 ) :300 ~ 305.
  • 2Coffey CE, Wilkinson WE, Weiner RD, et al. 1993. Quantitative cerebral anaromy in depression . A controlled magnetic resonance imaging study ,Archives of General Psychiatry ,50( 1 ) :7 ~ 16.
  • 3Moore GJ, Bebchuk JM, Hasanat k, et al. 2000. Lithium increases Naspartate in the hrman brain:in vivo evidence in support of bcl -2's neurotrophic effects? Biological Psychiatry,48( 1 ) :1 ~ 8.
  • 4Sheline YI ,Wang PW,Gado MH ,et al. 1996. Hippocampal atrophy in recurrent major depression. Proceeding of the National Academy ofSciences,93(9):3908~13.
  • 5侯钢,张心保,陈珏,姚辉,张石宁,翟书涛.抑郁症患者中枢单胺类神经递质相互关系的对照研究[J].中国神经精神疾病杂志,2002,28(1):7-7. 被引量:16
  • 6Yatnam LN,Liddle PF,Shiah IS ,et al. 2000. Brain serotonin2 receptors in major depression: a positron emission tomography study. Archives of General Psychiatry,57 (9) :850~ 8.
  • 7Whale R,Clifford EM, ,Bhagwagar Z,et al. 2001. Decreased sensitivity of 5 - HT(ID) receptor in melancholic depression. The British Journal of Psychiatry,178:454 ~457.
  • 8Takedayashi M, Kagaya A, Uchitomi Y, et al. 1998. Plasma dehydroepiandrosterone sulfate in unipolar major depression. Short communication. Journal of Neural Transmission, 105 (4 ~ 5 ) :537 ~ 42.
  • 9Rubin RT,Phillips JJ,McCracken JT,et al. 1996. Adrenal gland colume in major depression relationship to basal and stimulated pituitary -adrenal cortical axis function. Biological Psychiatry,40(2) :89 ~97.
  • 10Catalan R, Gallart JM, Castellanos JM, et al. 1998. Plasma corticotropin- releasing factor in depressive disorders. Biological Psychiatry,44(1) :15 ~20.

二级参考文献9

  • 1[1]Engstrom G, Alling C, Blennow K, et al. Reduced cerebrospinal HVA concentrations and HVA/5-HIAA ratios in suicide attempters. Monoamine metabolites in 120 suicide attempters and 47 controls. Eur Neuropsy-chopharmacol, 1999,9(5): 399.
  • 2[2]Goodwin FK, Jamison KR. Manic-depressive illness. New York and Oxford: Oxford University Press, 1990. 416-447.
  • 3[3]Reddy PL, Khanna S, Subhash MN, et al. CSF amine netabolites in depression. Biol Psychiatry, 1992, 31(2): 112.
  • 4[4]Nordin C, Siwers B, Bertilsson L. Bromocriptine treatment of depressive disorders. Clinical and biochemical effects. Acta Psychiatr Scand, 1981,64(1): 25.
  • 5[5]BertilssonL, Tuck Jr, SiwersB. Biochemical effects of zimeldine in man.Eur J Clin Pharmacol, 1980, 18(5): 483.
  • 6[6]Peabody CA, Faull KF, King R J, et al. CSF amine metabolites and depression. Psychiatry Res, 1987, 21(5):1.
  • 7[7]Hsiao JK, Agren H, Bartko JJ, et al. Monoamine neurotransmitter interactions and the prediction of antidepressant response, Arch Gen Psychiatry, 1987, 44(12): 1078.
  • 8[8]Geracioti TD, Loosen PT, Ekhator NN, et al. Uncoupling of serotonergic and noradrenergic systems in depression: preliminary evidence from continuous cerebrospinal fluid sampling. Depress Anxiety, 1997,6(3): 89.
  • 9[9]Backman J, Alling C, Alsen M, et al. Changes of cerebrospinal fluid monoamine metabolites during long-term antidepressant treatment. Eur Neuropsychopharmacol, 2000, 10(5): 341.

共引文献15

同被引文献114

引证文献13

二级引证文献82

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部